Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-04-06Clinical Trial Update: Mammography SPECT With Rotating Slant Hole Collimator
A Johns Hopkins University-sponsored clinical trial evaluating Mammography SPECT with a rotating slant-hole collimator for breast cancer has…
-
CLINICAL_TRIALS withdrawal · 2018-04-05Clinical Trial Update: Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node [Phase 3]
A Phase 3 trial comparing axillary lymph node dissection to no dissection in breast cancer with a positive sentinel lymph node has been with…
-
CLINICAL_TRIALS withdrawal · 2018-03-22Clinical Trial Update: The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer Patients [Phase 3]
A Phase 3 clinical trial evaluating the effect of metoprolol on anesthesia requirements, analgesic needs, and pain in breast cancer patients…
-
CLINICAL_TRIALS withdrawal · 2018-03-15Clinical Trial Update: Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer [Phase 3]
A Phase 3 trial of adjuvant ribociclib with endocrine therapy for HR+/HER2- intermediate-risk early breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-02-26Clinical Trial Update: Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis [NA]
Clinical trial NCT01710293, sponsored by the VA Office of Research and Development, has been withdrawn. The study evaluated an intervention …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2018-02-05Clinical Trial Update: Iterative PICC Placement Versus Long Term Device [Phase 3]
A Phase 3 clinical trial comparing iterative PICC placement vs long-term device for breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-12-13Clinical Trial Update: Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases [Phase 1, Phase 2]
A Phase 1/2 clinical trial of genistein in patients undergoing external-beam radiation therapy for bone metastases was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-12-02Clinical Trial Update: Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery [Phase 2]
Phase 2 clinical trial update for everolimus in women with breast cancer that can be removed by surgery has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-28Clinical Trial Update: Vaginal DHEA for Women After Breast Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating vaginal DHEA for vaginal dryness and related quality-of-life symptoms in women after breast cancer has…
-
CLINICAL_TRIALS withdrawal · 2017-11-21Clinical Trial Update: Evaluation Of Lymph Nodes After Neoadjuvant Chemotherapy [NA]
Dana-Farber Cancer Institute's trial evaluating lymph node assessment after neoadjuvant chemotherapy for breast cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-14Clinical Trial Update: Genetic, Neurophysiological and Psychological Predictive Factors of Chronic Neuropathic Pain After Surgery for Breast Cancer [NA]
A clinical trial (NCT02944721) investigating genetic, neurophysiological, and psychological predictors of chronic neuropathic pain after bre…
-
CLINICAL_TRIALS withdrawal · 2017-10-18Clinical Trial Update: Evaluate Breast Masses Using a New Method of Ultrasound Contrast to Detect Abnormal Blood Flow in Breasts [NA]
A breast cancer imaging trial evaluating a new ultrasound contrast method to detect abnormal blood flow in breast masses has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-10-10Clinical Trial Update: Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients [Phase 2]
A Phase 2 trial evaluating a carboplatin, eribulin, and veliparib combination in stage IV breast and ovarian cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-09-15Clinical Trial Update: Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving Chemotherapy [Phase 3]
A Phase 3 trial evaluating a pegfilgrastim biosimilar in high-risk breast cancer patients receiving chemotherapy has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-08-28Clinical Trial Update: Assessment of Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in ER-positive, Her2-negative Early Breast Cancer [NA]
A trial evaluating whether a genomic test influences shared decisions on adjuvant chemotherapy for ER-positive, HER2-negative early breast c…
-
CLINICAL_TRIALS withdrawal · 2017-08-16Clinical Trial Update: A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease. [Phase 2]
Phase 2 trial of intravenous ibandronate (Bondronat) in breast cancer patients with metastatic bone disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-08-16Clinical Trial Update: Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn [Phase 4]
A Phase 4 clinical trial evaluating ketorolac for analgesia after autologous breast reconstruction has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-21Clinical Trial Update: A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
A pilot study evaluating tumor-derived exosomes as diagnostic and prognostic markers in breast cancer patients receiving neoadjuvant chemoth…
-
CLINICAL_TRIALS withdrawal · 2017-07-13Clinical Trial Update: Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
The clinical trial evaluating breast cancer risk in BRCA1/BRCA2 mutation carriers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-12Clinical Trial Update: L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer [Phase 1]
Phase 1 trial evaluating L-glutamine to alleviate taxane-induced neuropathy in breast cancer patients was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-11Clinical Trial Update: Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer [Phase 2, Phase 3]
Peregrine's Phase 2/3 study evaluating taxane chemotherapy with or without bavituximab for HER2-negative metastatic breast cancer has been w…
-
CLINICAL_TRIALS withdrawal · 2017-07-02Clinical Trial Update: CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors [Phase 1]
A Phase 1 trial evaluating CT-011 and a p53 genetic vaccine for advanced solid tumors was withdrawn; the study encompassed breast cancer, co…
-
CLINICAL_TRIALS withdrawal · 2017-06-27Clinical Trial Update: Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer [Phase 2]
Phase 2 study of intravenous ascorbic acid in women receiving adjuvant or neoadjuvant chemotherapy for early-stage breast cancer has been wi…
-
CLINICAL_TRIALS withdrawal · 2017-06-26Clinical Trial Update: Lenvatinib and Capecitabine in Patients With Advanced Malignancies [Phase 1]
A Phase 1 study of lenvatinib in combination with capecitabine for patients with advanced cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-06-07Clinical Trial Update: Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating lapatinib or trastuzumab before surgery with chemotherapy in patients with early breast cancer has been …